Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What will be the next scam for this stock? Possibly toothpaste that prevents the coronavirus?
I think the Germans are teaming up with the Middle East just like in WWII. We all know how that ended up for them.
How early? You've been saying that for three months now but you've been wrong. For all you know the 50k blocks selling right now are Vyera and they haven't done much.
Outstanding Shares - 300,639,710 up from 273 million. Of course these are only the ones the transfer agent knows about.
There are no restrictions on sale of shares, exercise of warrants or sale of shares converted to warrants issued to Vyera.
HIV - Monotherapy Label Extension
from 3/19/2020 Webinar
"Look at how many new indications he start and does not stick to one till completion."
Not quite right -
Started with Mono
FDA wanted a combo trial approved first
Started with HIV combo
Finished with HIV combo, FDA changed dosage and wanted additinal data, awaiting finalized BLA submission
Finished Mono, phase 3 interventional
Mono phase 3 pivotal should not be necessary, see my next post (label expansion)
Started GVHD
Stopped GVHD (focus on cancer)
Started GVHD (first patient injected)
Approved for clinical trial in NASH (trial not started)
Started 22 solid tumor clinical trial
Started discussions with China for distribution rights
Discussions ongoing with China, Japan and Taiwan
Even though your due diligence is abysmal you should know that leronlimab is not the same as lopinavir and ritonavir. The way that you can tell is that they use differing letters in a different order. I am glad I could be of service to you in rectifying an obvious mistake on your part.
With your claimed shorting of the stock with a rise in share price you're losing.
With 100,000 doses minus our wholesale - at 1/3rd of retail that should be $28 million, at 1/2 of retail it should be $47 million.
Current $1 a share up from .935. Tanking? No wonder you seem confused in regards to where this is going. Up is down and down is up.
Hmmm, JMJ Financial doesn't seem big enough for $100 million.
Your desperation smells like failure.
Given your track record no worries from me.
For someone not invested you're overly impatient.
What decade was that .77 supposed to happen?
Time to put AGC and Samsung on standby ready to produce leronlimab when sufficient results come in. 2 weeks for Samsung to produce a 600,000+ dose batch and 2-4 weeks for AGC depending on the type of bioreactor they're using.
Where's the logic? Vyera isn't going to do a massive stock dump and kill off their one chance at redemption and profitability.
It makes you wonder how many warrants have been exercised and how much cash the company has gained.
ps. It's always been expected the warrants would be exercised so it's not unexpected dilution.
You don't invest in companies with zero revenue?